0000000000253928

AUTHOR

Roberta Montalbano

showing 8 related works from this author

Polymerase Chain Reaction (PCR)

2008

Polymerase Chain Reaction RT-PCRSettore BIO/10 - BiochimicaReal Time PCR.
researchProduct

The mechanism by which histone deacetylase inhibitors sensitize hepatoma and colon cancer cells to TRAIL-induced apoptosis

2008

Settore BIO/10 - BiochimicaHDACI TRAIL cancer cells
researchProduct

Parthenolide sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis

2009

parthenolide HCC DR4 STAT-3Settore BIO/10 - Biochimica
researchProduct

IL PARTENOLIDE SENSIBILIZZA CELLULE DI EPATOCARCINOMA UMANO ALL' APOPTOSI INDOTTA DA TRAIL

2011

Settore BIO/10 - BiochimicaAPOPTOSIEPATOCARCINOMAPARTENOLIDE
researchProduct

Tumor models: in vivo applications

2008

Settore BIO/10 - BiochimicaAnimal models tumor
researchProduct

Synergistic interaction between Parthenolide and TRAIL induces apoptosis in human hepatocarcinoma cells.

2009

Partenolide, a natural compound used in traditional medicine for its anti-inflammatory activity, has recently shown anti-tumor and apoptotic effects. Our studies demonstrated that HepG2; Hep3B and SK-Hep1 hepatocarcinoma cells, which are resistant to human recombinant TRAIL, are potently sensitized to TRAIL-induced apoptosis by low doses of parthenolide resulting in a marked synergist effect. To clarify the mechanism that accounts for this interaction, we demonstrated that parthenolide/TRAIL combination markedly increased DR4 and DR5. These effects might be correlated with STAT proteins modifications. In fact parthenolide and parthenolide/TRAIL combination decreased STAT3 and STAT5 and thei…

Parthenolide HCC TRAILSettore BIO/10 - Biochimica
researchProduct

Cell Viability

2008

MTTLDHtrypan blueSettore BIO/10 - Biochimica
researchProduct

Il partenolide sensibilizza le cellule di epatocarcinoma all'apoptosi indotta da TRAIL

2009

epatocarcinoma TRAIL DR4 DR5 STAT-3.
researchProduct